# Ultomiris

NDC: 25682-025
Generic name: ravulizumab
Labeler / Manufacturer: Alexion Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20201009

FDA application: BLA761108

## Active ingredients

- RAVULIZUMAB: 300 mg/3mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25682-025"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25682-025
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a9a590d9-0217-43c7-908d-e62a71279791